TRIM24 and juvenile dermatomyositis: Erythroderma, which is reported in 15% of JDM patients, is more common in those with the anti-TIF1 antibody [32], and these characteristic cutaneous manifestations were known as palmar hyperkeratotic papules, psoriasis-like lesions, and hypopigmented and “red on white” telangiectatic patches in a previous report [33].